Friess Associates’s InfuSystem Holdings INFU Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
$1.42M Sell
147,893
-98,400
-40% -$862K 2.38% 25
2022
Q1
$2.41M Buy
246,293
+83,845
+52% +$1.08M 1.29% 35
2021
Q4
$2.77M Buy
162,448
+20,788
+15% +$330K 1.08% 37
2021
Q3
$1.85M Buy
141,660
+27,775
+24% +$453K 0.78% 63
2021
Q2
$2.37M Buy
113,885
+22,006
+24% +$445K 0.89% 46
2021
Q1
$1.87M Sell
91,879
-24,448
-21% -$458K 0.73% 58
2020
Q4
$2.19M Sell
116,327
-22,514
-16% -$339K 0.16% 79
2020
Q3
$1.78M Sell
138,841
-51,700
-27% -$672K 0.15% 85
2020
Q2
$2.2M Buy
190,541
+5,905
+3% +$67.9K 0.21% 79
2020
Q1
$1.57M Buy
+184,636
New +$1.67M 0.16% 84

Other funds holding INFU

Friess Associates's INFU Position: Q2 2022 in Review

Friess Associates reduced its InfuSystem Holdings (INFU) stake by 40% in Q2 2022, selling an estimated $862K and leaving 147,893 shares worth $1.42M. The position accounts for 2.38% of the portfolio, ranked #25.

Friess Associates first reported a position in INFU in Q1 2020 and has held it in 10 quarters since. The position peaked at $2.77M in Q4 2021. 67 funds tracked by Wall St. Rank hold INFU as of Q2 2022.

  • Friess Associates held 147,893 shares of InfuSystem Holdings worth $1.42M as of Q2 2022.
  • Friess Associates sold 98,400 InfuSystem Holdings shares in Q2 2022, an estimated $862K.
  • InfuSystem Holdings made up 2.38% of Friess Associates's portfolio in Q2 2022, its #25 holding.
  • Friess Associates first reported a position in InfuSystem Holdings in Q1 2020 and has held it in 10 quarters since.
  • Friess Associates's InfuSystem Holdings position peaked at $2.77M in Q4 2021.
  • 67 funds tracked by Wall St. Rank held InfuSystem Holdings as of Q2 2022.

Based on Friess Associates's 13F filing for Q2 2022, filed 15 Aug 2022.